Special Counsel Andrew Baluch was quoted in a September 13, 2013 Law360 article titled “5 Tips For Winning USPTO Review Under AIA.” The article discusses the institution of two new America Invents Act programs for challenging the validity of patents. Baluch was quoted saying, “It’s not enough to just say the patent would have been obvious without providing particular reasoning. We’ve seen some petitions denied because of conclusory arguments.” He also added, “These proceedings are being run far more like litigation than prosecution, but there are definite prosecution elements to them. It’s best to staff the case with a mix of lawyers that includes litigators and prosecutors.”
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.